The Day After COVID-19-Time to Rethink Oncology Clinical Research
JAMA Oncol
.
2021 Jan 1;7(1):23-24.
doi: 10.1001/jamaoncol.2020.4240.
Authors
Daniel V Araujo
1
,
Geoffrey A Watson
1
,
Lillian L Siu
1
Affiliation
1
Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
PMID:
32880604
DOI:
10.1001/jamaoncol.2020.4240
No abstract available
MeSH terms
COVID-19 / epidemiology*
Clinical Trials as Topic / methods*
Decision Making
Humans
Medical Oncology / methods*
Neoplasms / therapy*
Pandemics
SARS-CoV-2 / isolation & purification